Equitable Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,423
| Closed | -$447K | – | 465 |
|
|
2024
Q4 | $447K | Hold |
2,423
| – | – | 0.03% | 340 |
|
|
2024
Q3 | $477K | Sell |
2,423
-43
| -2% | -$8.47K | 0.03% | 324 |
|
|
2024
Q2 | $509K | Hold |
2,466
| – | – | 0.04% | 293 |
|
|
2024
Q1 | $668K | Buy |
2,466
+184
| +8% | +$49.9K | 0.05% | 249 |
|
|
2023
Q4 | $539K | Buy |
2,282
+576
| +34% | +$136K | 0.04% | 267 |
|
|
2023
Q3 | $334K | Hold |
1,706
| – | – | 0.03% | 324 |
|
|
2023
Q2 | $359K | Sell |
1,706
-229
| -12% | -$48.1K | 0.03% | 314 |
|
|
2023
Q1 | $391K | Sell |
1,935
-213
| -10% | -$43K | 0.03% | 297 |
|
|
2022
Q4 | $468K | Buy |
+2,148
| New | +$468K | 0.04% | 272 |
|